Qiagen has agreed to a $191 million deal to acquire STAT-Dx. The takeover will give Qiagen control of a pipeline of assay panels designed to diagnose infections affecting the respiratory and gastrointestinal systems.
{iframe}https://www.fiercebiotech.com/medtech/qiagen-inks-191m-deal-to-buy-infection-test-panel-firm-stat-dx{/iframe}